Cleared Traditional

K150663 - Diagnostic X-ray System

K150663 is an FDA 510(k) clearance for Diagnostic X-ray System, manufactured by Osko, Inc.. The device is a Class 2 Radiology device with product code KPR cleared through the Traditional 510(k) pathway after a 52-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2015
Decision
52d
Days
Class 2
Risk

K150663 is an FDA 510(k) clearance for the Diagnostic X-ray System. Classified as System, X-ray, Stationary (product code KPR), Class II - Special Controls.

Submitted by Osko, Inc. (Miami, US). The FDA issued a Cleared decision on May 7, 2015 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1680 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Osko, Inc. devices

FDA 510(k) Submission Details - K150663

510(k) Number K150663 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 16, 2015
Decision Date May 07, 2015
Days to Decision 52 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
55d faster than avg
Panel avg: 107d · This submission: 52d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KPR Device Classification - Class 2, Special Controls

Product Code KPR System, X-ray, Stationary
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1680
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Mtechgroup
DAVE KIM

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - KPR System, X-ray, Stationary

All 262
Devices cleared under the same product code (KPR) and FDA review panel - the closest regulatory comparables to K150663.
GF50A
K151419 · Samsung Electronics Co., Ltd. · Jun 2015
Visaris Avanse
K150725 · Visaris D.O.O. Belgrade · Jun 2015
Jumong Series
K150816 · Sg Healthcare Co, Ltd. · May 2015
Exam Vue DR
K142930 · Jpi Healthcare Co, Ltd. · Apr 2015
ELIAN Digital Diagnostic X-ray System
K150506 · Osko, Inc. · Apr 2015
GC85A
K150165 · Samsung Electronics Co., Ltd. · Apr 2015